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Objective. To determine whether (1) a decreased concentration of Lactobacilli allows S. pyogenes to grow; (2) S. pyogenes is able
to grow in the presence of healthy Lactobacillus concentrations; (3) S. pyogenes is capable of inhibiting Lactobacilli. Methods.O n e
hundred ﬁfty patient samples of S. pyogenes were mixed with four diﬀerent concentrations of L. crispatus and L. jensenii. Colony
counts and pH measurements were taken from these concentrations and compared using t-tests and ANOVA statistical analyses.
Results. Statistical tests showed no signiﬁcant diﬀerence between the colony counts of S. pyogenes by itself and growth when mixed
with Lactobacilli, and no signiﬁcant diﬀerence between the colony counts of S. pyogenes in the four diﬀerent concentrations of
Lactobacilli. Conclusion. The statistical data representing the growth of these two organisms suggests that Lactobacilli did not
inhibit the growth of S. pyogenes.A l s o ,S. pyogenes did not inhibit the growth of Lactobacilli.
1.Introduction
Lactobacillus bacteria (Lactobacilli) are large Gram positive
rods that exist as nonpathogenic microbiota. Lactobacilli
have been extensively studied due to their remarkable ability
toinhibitthegrowthofotherorganismsthroughbactericidal
activity and by producing lactic acid as a byproduct of
metabolism [1, 2]. Lactic acid production, production of
bacteriocins, and the production of hydrogen peroxide
have led to an abundance of research involving the ability
of Lactobacilli to inhibit pathogens. Lactobacillus species
have proven eﬀective at inhibiting the growth of bacterial
and fungal pathogens which commonly cause vaginosis.
Lactobacillus species, speciﬁcally L. crispatus and L. jensenii,
are the predominant ﬂora in the vagina, and thus min-
imize opportunities for infection [3–8]. Several common
pathogens that Lactobacilli inhibit are: Candida albicans,
Escherichia coli (including E. coli O157:H7); and Neisseria
gonorrhoeae [1, 2, 5–9].
Due to their ability to inhibit other organisms, Lacto-
bacilli are commonly used for probiotic therapy to enhance
intestinal microbiota, as well as to treat vaginosis. The
principle of this treatment is to increase the concentration
of Lactobacilli, which will inhibit pathogens and allow the
body’simmunesystemtoovercometheinfectionwithoutthe
use of antimicrobials [8, 9].
Streptococcuspyogenes, often referred to as Group A strep,
is a Gram positive coccus which tends to group together in
chains. S. pyogenes causes the infection commonly known as
“strepthroat”andisthecauseof90%ofbacterialpharyngitis
cases. It can cause impetigo, erysipelas (cellulitis), toxic
shock syndrome, and necrotizing fasciitis (also known as
“ﬂesh-eating strep”). Untreated infections may lead to acute
glomerulonephritis, scarlet fever, or rheumatic fever. It has
many virulence factors that contribute to its pathogenic-
ity, such as lipoteichoic acid, M protein, hyaluronidase,
protease, streptokinase, DNase/RNase, C5a peptidase, and
Streptolysins O and S. These allow the bacteria to hemolyze
blood cells, spread throughout the body, adhere to surfaces,
and necrotize tissues [10].
S. pyogenes can exist in the vagina [4], but it was not
previously considered a cause of bacterial vaginosis [11–
13]. However, the recorded incidence of bacterial vaginosis
caused by S. pyogenes has increased during the past two2 Infectious Diseases in Obstetrics and Gynecology
decades [14–16]. Studies regarding this increased prevalence
suggest that the pathogen is introduced to the genital area by
persons that carry S. pyogenes in their respiratory tract either
as normal ﬂora or as a pharyngeal infection [11, 12, 17–20].
In response to the increase in occurrence, many laboratories
are beginning to make changes to protocols regarding the
detection of S. pyogenes. Many protocols now include S.
pyogenes as a potential vaginal pathogen that, in addition to
othervaginalpathogens,needstobeidentiﬁedwhenpresent.
Research indicates that in most cases of bacterial vagi-
nosis, the Lactobacillus concentration is notably decreased
[9, 20, 21], thus allowing an infection to take place. The
decreased concentration of Lactobacilli is often due to the
use of antimicrobials. This study addresses the following
questions.
(1) Does a decreased concentration of Lactobacilli allow
S. pyogenes to grow?
(2) Is S. pyogenes able to grow in the presence of healthy
Lactobacillus concentrations?
(3) Is S. pyogenes capable of inhibiting Lactobacilli?
Previous studies show that the average healthy vagina
has a concentration of about 106 colony-forming units per
milliliter (CFU/mL) of Lactobacilli. The average healthy
vaginal pH is about 3.5–4.8 [3, 4, 15, 22]. Although
uncommon, the pH can reach as high as 8.0, depending
on which part of the menstrual cycle is occurring. The
ﬂuctuation of hormone levels associated with the menstrual
cycle aﬀects the concentration of Lactobacilli, leading to a
ﬂuctuation in pH. Symptomatic cases of vaginosis usually
have low concentrations of Lactobacilli, accompanied by an
increased pH (≥7.0) [1, 4, 5, 23].
2.MaterialsandMethods
In order to minimize variation in Lactobacillus species that
might be found in clinical specimens, strains of L. crispatus
and L. jensenii were purchased from the American Type
CultureCollection(ATCC).L.crispatus(ATCC33197)andL.
jensenii (ATCC 25258) were mixed in sterile Columbia broth
(Fisher Scientiﬁc, Pittsburgh, PA) to concentrations of 108,
106,1 0 4,a n d1 0 3 CFU/mL [23]. The 106 is representative of
the average Lactobacillus concentration in a healthy female
[5]. A higher than average concentration was set up to
represent the females who have more Lactobacillus,a l o n g
with two lower concentrations to represent individuals who
would be at a higher risk of infection. Columbia broth
was chosen because it did not favor the growth of either
organism, and it allowed the ﬂuctuations in pH to be
measured easily.
The source of bacterial vaginosis caused by S. pyogenes
is suspected to be the throat, so 150 positive S. pyogenes
throat screens were donated by Ogden Clinic in Ogden,
Utah. Personal identiﬁcation information of each patient
was removed by the clinic before donating the samples,
earning this study an exempt status from the Weber State
University Institutional Review Board approval. Subcultures
were performed in order to isolate and verify the identity of
S.pyogenes.Researchindicatesthattheaverageconcentration
of pathogens which cause bacterial vaginosis is about
103 CFU/mL [16]. However, the concentration of S. pyogenes
in saliva has not yet been studied. A preliminary experiment
was conducted to determine a concentration to use. For
this preliminary experiment, concentrations of S. pyogenes
at 102 and 103 CFU/mL were grown with Lactobacilli at
106 CFU/mL. A concentration of 103 CFU/mL was used,
based on the colony counts from these concentrations.
A nephelometer, which is an instrument that measures
the turbidity of liquid solutions, was used to measure the
concentrations of the bacteria in the broth preparations,
followed by serial dilutions to achieve the various desired
concentrations. Three mL preparations of S. pyogenes at
103 CFU/mL were mixed with three mL of each of the four
diﬀerent concentrations of Lactobacilli. Each of these four
mixtures was then plated on Columbia Sheep Blood Agar
(SBA) (Fisher Scientiﬁc, Pittsburgh, PA) using calibrated
1.0μL loops. The broth mixtures and SBA plates were
incubatedinacarbondioxideincubatorat37
◦Cfor48hours.
After 48 hours, colonies were counted on the SBA plates,
and pH measurements were taken from each broth mixture.
Colonies were counted at 48 hours because the Lactobacillus
colonies were larger and easier to count after 48 hours. There
was no diﬀerence in colony counts or pH levels between 24
and 48 hours.
To validate the methodology used in this study, the same
process was repeated using Escherichia coli, Streptococcus
agalactiae (Group B strep), Staphylococcus epidermidis,a n d
Staphylococcus aureus, which are known to be inhibited by
Lactobacilli. Each of these was plated on an SBA plate before
mixing with the Lactobacillus concentrations to compare to
the growth in the presence of Lactobacilli. One hundred
μL were taken from the broth preparations before mixing
with the Lactobacilli and were incubated along with the
mixtures. The pH of the broth without Lactobacilli was taken
after incubation to compare to the pH of that pathogen
mixed with Lactobacilli. The growth of each pathogen used
was inhibited by the Lactobacilli, and the broth pH was
lowered. Utilizing these pathogens as controls proves that the
conditions used in the methodology allowed the Lactobacilli
to inhibit other organisms as they would in the body.
3. Results and Discussion
In each of the samples, no inhibition of S. pyogenes by
L. crispatus and L. jensenii was observed. Statistical tests (t-
tests with an alpha level of α = 0.01) showed no signiﬁcant
diﬀerence between the colony counts of S. pyogenes by itself
and growth when mixed with Lactobacilli. In the case of
mostpathogens,ahigherconcentrationofLactobacilliwould
cause more inhibition. However, statistical tests (ANOVA,
α = 0.01) also showed no signiﬁcant diﬀerence between
the colony counts of S. pyogenes in the four diﬀerent
concentrations of Lactobacilli.T h ed i ﬀerence in colony-
forming units for each S. pyogenes isolate was most likely due
to technical error during the serial dilutions and/or random
error due to the diﬀering strains of S. pyogenes.Infectious Diseases in Obstetrics and Gynecology 3
Table 1: Average growth and pH of the broth mixtures.
Colony counts from broth mixtures 108 CFU/mL
Lactobacilli
106 CFU/mL
Lactobacilli
104 CFU/mL
Lactobacilli
103 CFU/mL
Lactobacilli
Average colony counts of Lactobacilli >100 >100 10 4
Average colony counts of S. pyogenes 13 14 13 11
Average pH 6.0 6.5 6.5 6.5
4.555 .566 .577 .58
pH
0
10
20
30
40
50
60
70
80
90
100
Average growth at varying pH
T
o
t
a
l
g
r
o
w
t
h
(
%
)
E. coli
S. agalactiae
S. aureus
S. pyogenes
S. epidermidis
Lactobacilli
Figure 1: Percent of total growth of each organism comparing
growth with Lactobacilli to growth without Lactobacilli. These data
were taken from the results of this study.
The pH of the broth for each sample was reduced from
the starting pH of 8.5 to a pH range of 4.5–7.0. The pH
of the broth only containing S. pyogenes ranged from 5.5 to
6.5, suggesting that S. pyogenes grows optimally in an acidic
environment [5]. Table 1 summarizes the average colony
countsandpHofthemixturesofS.pyogenesandLactobacilli.
Limitations of this study included the elevated pH
of the broth medium and technical error associated with
serial dilutions. The process of serial dilutions allowed the
possibility of pipetting error which may have inﬂuenced the
colony counts. The elevated pH of the broth medium did not
allow any data at a pH lower than 4.5. It is also possible that
the alkaline pH of the broth medium impacted inhibition of
the Lactobacilli and/or S. pyogenes.
Additional studies that further investigate the prevalence
and clinical signiﬁcance of bacterial vaginosis caused by
S. pyogenes would add to the current body of knowledge on
this topic.
4. Conclusions
Figure 1 shows the growth patterns of the organisms used in
this study. With the exception of S. pyogenes and S. epider-
midis, the pathogens grew optimally in conditions where the
Lactobacillus concentrations were decreased. S. epidermidis is
normal skin ﬂora and is inhibited to nonpathogenic levels by
the Lactobacilli within the vagina. S. pyogenes grew optimally
in the same conditions as the Lactobacilli. It is possible that
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Figure 2: Average growth of S. pyogenes, suggesting that Lactobacilli
may assist the growth of S. pyogenes.
higher concentrations of Lactobacilli may assist the growth of
S. pyogenes, as shown in Figure 2.
It is suggested that medical personnel treat vaginosis
caused by S. pyogenes using antimicrobial therapy, as they
would treat other S. pyogenes infections. It is also suggested
that Lactobacillus probiotic therapy not be used as the sole
means to treat bacterial vaginosis caused by S. pyogenes.
The statistical data representing the growth of these two
organismssuggestthatLactobacillididnotinhibitthegrowth
of S. pyogenes. Also, S. pyogenes did not inhibit the growth of
Lactobacilli.
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